Testosterone undecanoate improves sexual function in men with type 2 diabetes

In a recent placebo-controlled study, long acting testosterone undecanoate (an ester of testosterone) improved erectile function, intercourse satisfaction, and sexual desire scores in type 2 diabetic men with severe hypogonadism, a condition in which the body doesn't produce enough testosterone.

Only sexual desire improved significantly with replacement therapy in those with mild hypogonadism.

"The study's results also suggest that trials of should be for a minimum of 6 months and not shorter periods as suggested by some guidelines," said Dr. Geoffrey Hackett, lead author of the BJU International study.

Explore further

Testosterone undecanoate cuts anemia in hypogonadal men

More information: Geoffrey Hackett et al, Testosterone Undecanoate improves Sexual Function in Men with Type 2 diabetes and Severe Hypogonadism: Results from a 30 week randomized placebo controlled study, BJU International (2016). DOI: 10.1111/bju.13516
Provided by Wiley
Citation: Testosterone undecanoate improves sexual function in men with type 2 diabetes (2016, May 6) retrieved 20 October 2019 from https://medicalxpress.com/news/2016-05-testosterone-undecanoate-sexual-function-men.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more